About Us
entrotech life sciences inc
Formed in 2012, entrotech life sciences (ELS) is a privately held materials science company that specializes in thin film technologies. By leveraging the innovation and manufacturing capabilities of the parent company, entrotech, inc., ELS is pioneering chlorhexidine-impregnated film technology.
The entrogroup of companies first introduced non-antimicrobial polymer film technology into tactical combat casualty care products for the United States Military's Special Forces, where its first priority was saving lives. That same mandate has not changed, and ELS has since developed PrevahexCHX to offer an innovative new infection control technology to hospitals worldwide. ELS exists to save lives.
Founder and CEO, Jim McGuire, has more than 75 patents for innovative technologies and processes – all inspired by and directed towards solving real-world problems.
_____
Jim McGuire
President and CEO of entrogroup
Jim McGuire founded entrogroup in 1999 with the vision to solve problems, save lives and provide opportunities for students to learn and grow. After deploying seven advanced life-saving products to battle environments around the world, Jim set out to create a new paradigm in healthcare, creating PrevahexCHX, an inventive chlorhexidine polymer delivery device, in 2014.
Jim currently holds 81 issued and pending patents. He has a BS in chemistry from The Ohio State University where he received an internship with Dupont that changed his goal of achieving a PhD in chemistry to focus on a multifunctional career based on the combination of business and science. At Ohio State University he serves on the Technology Oversight Committee for the Department of Chemistry and on the advisory board for the Institute of Materials Research.
Jim and his family live in Palm Beach, Florida, for nine months of the year, and spend their summers in Columbus, Ohio. He has a passion for motorsports, and currently drives an LMP3 in the Michelin Le Mans Cup in Europe.
Meet the Leadership Team
Dr. Ken Moritsugu
medical director
Dr. Kenneth P. Moritsugu
M.D., M.P.H., F.A.C.P.M. - Rear Admiral, USPHS (Retired)
Dr. Kenneth Moritsugu is the President and CEO of First Samurai Consulting, LLC, a firm specializing in health consulting focused on public health systems and policies.
Rear Admiral Moritsugu was the Acting Surgeon General of the United States, in 2002 and again from July 2006 until September 2007. He has been the recipient of numerous awards and recognitions such as the Surgeon General’s Medallion with two gold stars. Dr. Moritsugu was a career officer in the USPHS for 37 years and has a personal expertise in organ and tissue donation and transplantation.
He received his bachelor’s degree from the University of Hawaii, a medical degree from the George Washington University School of Medicine and a Master of Public Health in health administration and planning from the University of California, Berkeley.
Jack Querio
senior vice president of sales
Jack Querio
Senior Vice-President, Sales
Jack Querio has spent over 35 years in the biotech, medical device, pharmaceutical and health care consumer products industries in senior management roles. He has worked with companies such as Johnson & Johnson, VWR International and Medline Industries, leading national account and government teams and national field sales organizations. He holds awards, such as the prestigious “Chairman’s Award” from Johnson & Johnson and has extensive experience on Capitol Hill working with lobbyists, patient advocacy groups, congressional leaders/staff and legal entities to advance patient care and safety. Jack holds a bachelor’s degree in health science from Western Illinois University and is a graduate of the Wharton Executive Management Academy of the Leonard Davis Institute of Health Economics at the University of Pennsylvania.
Melanie Waddell
vice president of marketing
Melanie Waddell
Vice-President, Marketing
Melanie has been an infection prevention marketer for over 10 years and is passionate for products that save lives. Previously, she worked at PDI where she managed and developed products and programs for FDA regulated products (drug and medical devices), EPA regulated products and cosmetic products used in the prevention of healthcare and community associated infections. She has a Master of Business Administration (MBA) from Baruch College in New York City and bachelor degrees from the University at Albany, State University of New York in both business administration with a marketing concentration and psychology.
Dr. George Holinga
chief technology officer
George Holinga Ph.D.
Chief Technology Officer
Dr. George Holinga serves as the Chief Technology Officer at entrotech life sciences inc. where he has played a significant role in the development and execution of its product portfolio since 2010. Prior to entrotech life sciences, George worked as a graduate student research assistant at Lawrence Berkeley National Laboratory, investigating the surface science of biomaterials. He has also served as a scientific consultant working on the development of prototype blood purification therapy products.
George holds a Ph.D. in physical chemistry from the University of California, Berkeley and a Bachelor of Science in both chemistry and physics from Ohio State University. He has published multiple peer-reviewed articles on topics ranging from biomolecular surface science to the development of new, non-linear spectroscopic techniques.